June 2026: A major Pinot Noir clonal trial in Central Otago is providing grape growers and winemakers with new insights into how different clones perform under identical vineyard conditions.

Established by Riversun Nursery and Otago Polytechnic, and analysed by the Bragato Research Institute (BRI), the trial compares 12 commercially available Pinot Noir clones grown on the same site, rootstock and soils at Bannockburn.

The research combined vineyard measurements, wine chemistry and sensory evaluation across the 2024 and 2025 vintages. While seasonal conditions proved to be the biggest driver of variation between wines, the study identified consistent clonal differences in ripening, colour intensity, phenolic composition and flavour profiles.

Clone 943 stood out for its deeper colour, stronger phenolic structure and greater complexity, while MV6 also showed high phenolic concentration. Abel and AM 10/5 produced higher yields but required more careful crop management to achieve desired ripeness levels.

Researchers say the findings highlight the importance of matching clone selection to site and wine style, while supporting the use of mixed-clone plantings to improve resilience and blending options in New Zealand vineyards.

Pinot noir grape vines. Photo: Bragato Research Institute.

May 2026: IRANZ Chair Dr John McDermott says the 2026 Budget reflects an ongoing shift toward strategic priorities, commercialisation, and mission-led investment, but appears to rely largely on reprioritisation of existing funding rather than significant new investment in research capability - potentially leaving the country in a vulnerable position.

He says New Zealand's research system is a critical national asset that underpins economic resilience, environmental stewardship, public wellbeing, and informed decision-making. As the Government continues implementing reforms to the science, innovation and technology system, including development of the Transition Research Fund, Dr McDermott says it is important that New Zealand maintains strong, locally grounded research capability across all disciplines.

"Research is not a luxury for New Zealand - it is part of how we improve productivity, strengthen resilience, support better policy, and create opportunities for future generations," says Dr McDermott.

"International evidence consistently shows that countries investing in research and development achieve stronger long-term economic performance."

Dr John McDermott presenting on the economy at the Speaker's Science Forum at Parliament in 2021. Image: Emma Williams, Motu.